Effects of redox state on the efficient uptake of cell permeable peptide in mammalian cells

Open Biochemistry Journal

Volumn 7, Issue 1, 2013, Pages 54-65

  Squires, Shayne ^a   Christians, Elisabeth ^a   Riedel, Michael ^a   Timothy, David ^b   Rodesch, Christopher K ^a   Marvin, James ^a   Benjamin, Ivor ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Cell penetrating peptides; FRET; Glutathione; Model amphipathic peptide; Redox

Indexed keywords

ACETYLCYSTEINE; CELL PENETRATING PEPTIDE; FLUORESCEIN AMIDITE; FLUORESCENT DYE; GLUTATHIONE; GREEN FLUORESCENT PROTEIN; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CONTROLLED STUDY; DISULFIDE BOND; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MAMMAL CELL; MOLECULAR DYNAMICS; MOLECULAR IMAGING; NEWBORN; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84884181980     PISSN: None     EISSN: 1874091X     Source Type: Journal    
DOI: 10.2174/1874091X20130531001     Document Type: Article

References (43)

1. Kilk K, Mahlapuu R, Soomets U, Langel U. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling, Toxicology. 2009; 265: 87-95.
2. Steiner V, Schär M, Börnsen KO, Mutter M. Retention behavior of a template-assembled synthetic protein and its amphiphilic building blocks on reversed-phase columns, J. Chromatogr. 1991; 586: 43-50.
3. Langel U., Cell-Penetrating Peptides: Processes and Applications. Boca Raton, FL: CRC Press; 2002.
4. Oehlke J, Krause E, Wiesner B, Beyermann M, Bienert M. Nonendocytic amphipathicity dependent cellular uptake of helical model peptides, Protein Pept. Lett. 1996; 3: 393-398.
5. Oehlke J, Scheller A, Wiesner B, Krause E, Beyermann M, Klauschenz E, Melzig M, Bienert M. Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically, Biochim. Biophys. Acta. 1998; 1414: 127-39.
6. Säälik P, Niinep A, Pae J, Hansen M, Lubenets D, Langel Ü, Pooga M. Penetration without cells membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles, J. Controlled Release. 2011; 153: 117-125.
7. Scheller A, Wiesner B, Melzig M, Bienert M, Oehlke J. Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides, Eur. J. Biochem. 2000; 267: 6043-6049.
8. Deshayes S, Morris MC, Divita G, Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics, Cell Mol. Life Sci. 2005; 62: 1839-1849.
9. Koren E, Torchilin VP. Cell-penetrating peptides: breaking through to the other side, Trends Mol. Med. 2012; 18: 385-393.
10. Zhang XX, Eden HS, Chen X. Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates, J. Control. Release. 2012; 159: 2-13.
11. Mo RH, Zaro JL, Shen WC. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy, Mol. Pharm. 2012; 9: 299-309.
12. Wolf Y, Pritz S, Abes S, Bienert M, Lebleu B, Oehlke J. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides, Biochemistry. 2006; 45: 14944-14954.
13. Kenien R, Shen WC, Zaro JL. Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide, J. Drug Target. 2012; 20: 793-800.
14. Hällbrink M, Florén A, Elmquist A, Pooga M, Bartfai T, Langel U. Cargo delivery kinetics of cell-penetrating peptides, Biochim. Biophys. Acta. 2001; 1515: 101-109.
15. Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators, J Biol. Chem. 2004; 279: 22284-93.
16. Gutscher M, Pauleau AL, Marty L, Brach T, Wabnitz GH, Samstag Y, Meyer AJ, Dick TP. Real-time imaging of the intracellular glutathione redox potential, Nat. Methods. 2008; 5: 553-9.
17. Morgan B, Sobotta MC, Dick TP. Measuring EGSH and H2O2 with roGFP2-based redox probes, Free Radic. Biol. Med. 2011; 51: 1943-51.
18. VanLith M, Tiwari S, Pediani J, Milligan G, Bulleid NJ. Real-time monitoring of redox changes in the mammalian endoplasmic reticulum, J. Cell Sci. 2011; 124: 2349-56.
19. Zhang H, Limphong P, Pieper J, Liu Q, Rodesch CK, Christians E, Benjamin IJ. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity, FASEB J. 2012; 26: 1442-51.
20. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple, Free Radic. Biol. Med. 2001; 30: 1191-1212.
21. Ning JL, Mo LW, Lai XN. Low- and high-dose hydrogen peroxide regulation of transcription factor NF-E2-related factor 2, Chin. Med. J. 2010; 123: 1063-9.
22. Haendeler J, Tischler V, Hoffmann J, Zeiher AM, Dimmeler S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression, FEBS Lett. 2004; 577: 427-33.
23. Jarrett SG, Boulton ME. Antioxidant up-regulation and increased nuclear DNA protection play key roles in adaptation to oxidative stress in epithelial cells, Free Radic. Biol. Med. 2005; 38: 1382-91.
24. Sen P, Chakraborty PK, Raha S. p38 mitogen-activated protein kinase (p38MAPK) upregulates catalase levels in response to low dose H2O2 treatment through enhancement of mRNA stability, FEBS Lett. 2005; 579: 4402-6.
25. BoseGirigoswami K, Bhaumik G, Ghosh R. Induced resistance in cells exposed to repeated low doses of H2O2 involves enhanced activity of antioxidant enzymes, Cell Biol. Int. 2005; 29: 761-7.
26. Chiaradia E, Gaiti A, Scaringi L, Cornacchione P, Marconi P, Avellini L. Antioxidant systems and lymphocyte proliferation in the horse sheep and dog, Vet. Res. 2002; 33: 661-8.
27. Jung HI, Lim HW, Kim BC, Park EH, Lim CJ. Differential thioredoxin reductase, activity from human normal heptic and hepatoma cell lines, Yonsei Med. 2004; 45(2): 263-72.
28. Lee J, Dawes IW, Roe JH. Adaptive response of schizosaccharomyces pombe to hydrogen peroxide and menadione, Microbiology. 1995; 141: 3127-32.
29. Hällbrink M, Oehlke J, Papsdorf G, Bienert M. Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration, Biochim. Biophys. Acta. 2004; 1667: 222-8.
30. Bychkov R, Pieper K, Ried C, Milosheva M, Bychkov E, Luft FC, Haller H. Hydrogen peroxide potassium currents and membrane potential in human endothelial cells, Circulation. 1999; 99: 1719-25.
31. Fearon IM, Palmer ACV, Balmforth AJ, Ball SG, Varadi G, Peers C. Modulation of recombinant human cardiac L-type Ca2+ channel α1c subunits by redox agents and hypoxia, J. Physiol. 1999; 514: 629-37.
32. Poteser M, Graziani A, Rosker C, Eder P, Derler I, Kahr H, Zhu MX, Romanin C, Groschner K. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel, J. Biol. Chem. 2006; 281: 13588-95.
33. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK, Wang R, Amzel LM, Berkowitz DE, Snyder SH. Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels, Circ. Res. 2011; 109: 1259-68.
34. Aw TY. Cellular redox: a modulator of intestinal epithelial cell proliferation, New Physiol. Sci. 2003; 18: 201-4.
35. Filomeni G, Rotilio G, Ciriolo MR. Cell signaling and the glutathione redox system, Biochem. Pharmacol. 2002; 64: 1057-64.
36. Menon SG, Goswami PC. A redox cycle within the cell cycle: ring in the old with the new, Oncogene. 2007; 26: 1101-9.
37. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signaling in cardiac hypertrophy and heart failure, Heart. 2007; 93: 903-7.
38. Elahi MM, Kong YX, Matata BM. Oxidative stress as a mediator of cardiovascular disease, Oxid. Med. Cell Longev. 2009; 2: 259-69.
39. Nakamura T, Lipton SA. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases, Apoptosis. 2010; 15: 1354-63.
40. Acharya A, Das I, Chandhok D, Saha T. Redox regulation in cancer a double-edged sword with therapeutic potential, Oxid. Med. Cell Longev. 2010; 3: 23-34.
41. Sato N, Iwata S, Nakamura K, Hori T, Mori K, Yodoi J. Thiol-mediated redox regulation of apoptosis.Possible roles of cellular thiols other than glutathione in T cell apoptosis, J. Immunol. 1995; 154: 3194-203.
42. Hampton MB, Fadeel B, Orrenius S. Redox regulation of the caspases during apoptosis, Ann. N. Y. Acad. Sci. 1998; 854: 328-35.
43. Hampton MB, Orrenius S. Dual regulation of caspases activity by hydrogen peroxide: implications for apoptosis, FEBS Lett. 1997; 414: 552-6.